With Alkermes’ Transition Well Under Way, Commercial Expansion Is Next
Executive Summary
As Alkermes advances its proprietary pipeline, the company is beginning to build its commercial organization ahead of what will be the launch of its first wholly owned drug since it took the marketing reins with Vivitrol in 2008.